Core Insights - The Biologics X 3DCC Summit 2026 is a significant event merging two influential scientific conferences in India, focusing on biopharmaceutical product development and advances in 3D cell culture [1][2] Event Overview - The summit will take place on January 22-23, 2026, at Novotel Dona Sylvia Resort, Goa, India, and is expected to attract over 800 global leaders in biologics, biosimilars, and cell-based technologies [1][2] Purpose of Merging Events - The integration of Biologics and 3DCC aims to address adoption bottlenecks in advanced 3D cell culture technologies for developing monoclonal antibodies, cell and gene therapies, and other next-generation modalities [3][4] Industry Collaboration - The summit will facilitate cross-sector dialogue and collaboration, promoting large-scale implementation of innovative therapies and enhancing accessibility in the biopharma industry [4][6] Regulatory Alignment - The event is timely as global regulators, including the US FDA, are increasingly adopting human-relevant, non-animal testing models, helping Indian stakeholders align with these trends [5][6] Conference Features - The two-day conference will include pre-conference workshops, three parallel scientific tracks focusing on 3D cell culture and biologics, poster sessions for early-career researchers, and a startup innovation showcase [7][11] Networking and Collaboration Opportunities - Participants will have the chance to gain insights, forge strategic collaborations, and engage in curated networking opportunities tailored for partnerships and policy discussions [8][11] Call to Action - The summit invites scientists, innovators, and leaders to contribute to shaping the future of biopharma in India, emphasizing the shift towards novel biologics and non-animal testing models [8][9]